Doxepin Hydrochloride Capsule
Product Images NDC 71335-2817

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxepin Hydrochloride (NDC 71335-2817). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pic (56645f3c 452a 404f Ad51 2dab95f23e6e 01)

Chemical structure of doxepin hydrochloride, showing the molecular framework including aromatic rings and a tertiary amine group with attached methyl groups, along with the hydrochloride salt component.*

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 1)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 2)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 3)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 4)

FDA Label Image

Image (56645f3c 452a 404f Ad51 2dab95f23e6e 316 5)

FDA Label Image

Label (Lbl713352817)

Doxepin Hydrochloride Capsules, USP 25 mg oral capsules label showing 30 capsules per package. Label includes storage instructions, child-resistant container warning, manufacturer Mankind Pharma Ltd., and repackager Bryant Ranch Prepack, Inc. Identifiers include NDC 71335-2817-1 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.